TrialScientific reports2025

A single-center, single-arm, prospective, open-label, and comparative trial to evaluate the safety and tolerability profile of a 90-day oral L-arginine hydrochloride intervention for patients with amyotrophic lateral sclerosis.

Hiroyuki Naito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.